Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person ALK del318-782 [plasma membrane]

Class:Id	EntityWithAccessionedSequence:9723869
_displayName	ALK del318-782 [plasma membrane]
_timestamp	2021-03-18 18:20:01
compartment	[Compartment:876] plasma membrane
created	[InstanceEdit:9723871] Rothfels, Karen, 2021-03-18
disease	[Disease:9671652] neuroblastoma
endCoordinate	1620
hasModifiedResidue	[FragmentDeletionModification:9723858] Deletion of residues 318 to 782
literatureReference	[LiteratureReference:9723824] Characterization of rearrangements involving the ALK gene reveals a novel truncated form associated with tumor aggressiveness in neuroblastoma
name	ALK del318-782 ALK tyrosine kinase receptor ALK_HUMAN
referenceEntity	[ReferenceGeneProduct:49894] UniProt:Q9UM73 ALK [Homo sapiens]
species	[Species:48887] Homo sapiens
stableIdentifier	[StableIdentifier:9723880] R-HSA-9723869.1
startCoordinate	19
(hasComponent)	[Complex:9723873] ALK del318-782 dimer [plasma membrane] [Homo sapiens]
(hasMember)	[CandidateSet:9700087] extracellular domain ALK mutants [plasma membrane] [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by ALK del318-782 [plasma membrane] (9723869)